Market Size –
The central lab market size has grown strongly in recent years. It will grow from $2.8 billion in 2023 to $3.04 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increased clinical trials growth, growth in drug development activities, regulatory compliance, increased healthcare research, growth in diagnostic testing.
The central lab market size is expected to see strong growth in the next few years. It will grow to $4.15 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing personalized healthcare, increasing biomarker research, increasing demand for telemedicine and remote monitoring, global health challenges, growing demand for precision diagnostics. Major trends in the forecast period include technological advancements, innovative solutions, strategic collaborations.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/central-lab-global-market-report
Scope Of Central Lab Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Central Lab Market Overview
Market Drivers –
The rise in the number of clinical trials is expected to drive the central lab market going forward. A clinical trial is a type of research study that is aimed at evaluating a new treatment, a new drug, or a medical device’s safety and effectiveness. Pharmaceutical and biotechnology companies outsource central labs for testing, development, and production of new products. For instance, according to ClinicalTrials.gov, a registry of clinical trials by the National Library of Medicine and a US-based medical library operated by the US federal government, as of July 2022, 422,646 clinical trials were listed as compared to 399,523 in 2021. Therefore, the rise in the number of clinical trials will promote the central lab market.
The central lab market covered in this report is segmented –
1) By Service Type: Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology or Histology, Specimen Management And Storage, Special Chemistry Services, Other Service Types
2) By Test Type: Human And Tumor Genetics, Clinical Chemistry, Medical Microbiology And Cytology, Other Esoteric Tests
3) By End-User: Pharmaceutical Companies, Academic And Research Institutes, Biotechnology Companies
Get an inside scoop of the central lab market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=7317&type=smp
Regional Insights –
North America was the largest region in the central lab market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the central lab market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major companies operating in the central lab market include Celerion Inc., Cerba Research, Cirion Biopharma Research Inc., Clinical Reference Laboratory Inc., Eurofins Central Laboratory LLC, Frontage Laboratories Inc., Icon Central Labs, Interlab Central Lab Services, InVitro International, LabConnect LLC, Labcorp Drug Development India Private Limited, Medpace Clinical Research India Private Limited, MLM Medical Labs GmbH, Q2 Solutions Pty Ltd., Sonic Healthcare Limited, Synevo Central Lab, Acm Global Laboratories Private Limited, ACM Global Laboratories, Altasciences, Barc Lab, BioIVT LLC, ICON plc, Intertek, LabNow LLC, Medidata Solutions, NAMSA LLC, Neoteryx, Northwell Health Labs, PAREXEL International, Pharm-Olam LLC, Pharmaceutical Product Development, PRA Health Sciences, Quest Diagnostics, IQVIA Co., Rho Inc.
Table of Contents
1. Executive Summary
2. Central Lab Market Report Structure
3. Central Lab Market Trends And Strategies
4. Central Lab Market – Macro Economic Scenario
5. Central Lab Market Size And Growth
…..
27. Central Lab Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
